SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000930413-13-003390
Filing Date
2013-06-12
Accepted
2013-06-12 17:00:01
Documents
7
Period of Report
2013-06-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 c74187_8k.htm 8-K 22981
2 c74187_ex99-1.htm EX-99.1 10024
3 c74187_ex99-2.htm EX-99.2 107037
4 GRAPHIC x1_c74187a001.jpg GRAPHIC 2677
5 GRAPHIC x1_c74187a002.jpg GRAPHIC 2885
6 GRAPHIC x1_c74187a003.jpg GRAPHIC 2677
7 GRAPHIC x1_c74187a004.jpg GRAPHIC 2885
  Complete submission text file 0000930413-13-003390.txt   157278
Mailing Address ENZO BIOCHEM INC 60 EXECUTIVE BLVD FARMINGDALE NY 11735
Business Address 60 EXECUTIVE BLVD FARMINGDALE NY 11735 5167555500
ENZO BIOCHEM INC (Filer) CIK: 0000316253 (see all company filings)

IRS No.: 132866202 | State of Incorp.: NY | Fiscal Year End: 0731
Type: 8-K | Act: 34 | File No.: 001-09974 | Film No.: 13909377
SIC: 8071 Services-Medical Laboratories